Live Webinar | Operations and Other Technology
Live Webinar | Patient Financial Communications
Live Webinar | Costing and Managerial Accounting
Blog | Medicare Payment and Reimbursement

Coverage denials based on medical necessity are far more likely to arise from Medicare FFS rules than from MA plan policies

Blog | Medicare Payment and Reimbursement

Coverage denials based on medical necessity are far more likely to arise from Medicare FFS rules than from MA plan policies

Coverage rules based on Medicare national and local determinations were the most likely source of claim denials in one Medicare Advantage plan.

When Medicare Advantage (MA) beneficiaries receive a coverage denial stemming from medical necessity criteria, Medicare fee-for-service rules are a more likely source compared with MA supplementary guidelines, according to a new study.

For a study (login required) published in the January issue of Health Affairs, researchers examined MA claims in Aetna’s database from 2014 through 2019. They found that 1.4% of services and 0.68% of total spending were denied, with rates rising over time (the study did not examine prior authorization requirements).

Among the denials, coverage rules in the traditional Medicare program (i.e., Medicare fee-for-service) accounted for 85% of denied services and 64% of denied spending, with Aetna MA rules accounting for the remainder.

The researchers found significant variation in denials rates based on service type and provider type, with lab services — especially in Medicare fee-for-service — and hospital outpatient providers being affected the most.

Laboratory claims “tend to be denied because they lack appropriate diagnosis codes,” the researchers wrote. “Medicare has instituted extensive diagnostic coding requirements for laboratory services; the most recent Medicare manual on laboratory diagnostic coding is more than 2,000 pages long. In contrast, MA insurer restrictions tended to affect rarer, higher-price services including chemotherapy.”

Among MA-based denials, the most common reasons were for services classified as experimental or investigational (61%) or as lacking proven efficacy (20%).

Of note, the researchers found 5,058 unique procedure codes in the denied claims. The most frequent was for glycosylated hemoglobin (A1C) testing, which was seen in 9% of denials.

The researchers reported that Aetna had 995 clinical policy bulletins in which it described coverage rules, while Medicare had 348 national coverage determinations (issued by CMS administrative staff) and 1,007 local coverage determinations (issued by Medicare administrative contractors for their specific jurisdictions).

One caveat to the findings, the researchers noted, was that even though a denial may have been attributed to Medicare FFS coverage rules, Aetna theoretically could be enforcing those rules more stringently than would be seen in traditional Medicare.

About the Author

Nick Hut

is a senior editor with HFMA, Westchester, Ill. (

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Medicare Payment and Reimbursement

Column | Value-Based Payment

Paul Keckley: 2 major changes in the value agenda require finance leaders’ attention

The value agenda in U.S. healthcare is critical to its future, but there are two key areas in which it is likely to be redirected in years to come.

Trendsetter | Value-Based Payment

Rethinking population health management: Why successful risk-based contracting requires provider empowerment

Find out how one company hopes to solve challenges of industry shifts from fee-for-service to value-based care by reversing the long-standing narrative that population health management isn’t possible or profitable.

News | Medicare Payment and Reimbursement

Medicare payments for 340B drugs are set to increase immediately after recent court ruling

The Medicare payment rate for drugs acquired through the 340B program must be increased by nearly 30 percentage points effective immediately, according to a court ruling.

Blog | Strategic Partnerships Mergers and Acquisitions

Healthcare News of Note: UnitedHealth Group can proceed with Change Healthcare purchase after a favorable decision in an antitrust case

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: UnitedHealth Group cleared to acquire Change Healthcare, standard patient satisfaction surveys need to address DEI issues, and homebound older adults contribute to higher levels of Medicare spending.